Current Neuro-Oncology
Volume
3 Number 2
28 February 2001
Home > Publications > Current Neuro-Oncology > Volume 3, Year 2001 > Number 2, 28 February
Mariani L, Schroth G, Wielepp JP,
Haldemann A, Seiler RW.
Intratumoral
arteriovenous shunting in malignant gliomas.
Neurosurgery.
2001 Feb;48(2):353-7∟.
doi: 10.1097/00006123-200102000-00022∟.
PMID: 11220379∟.
Case report. ˍ
Simmons ML, Lamborn KR, Takahashi
M, Chen P, Israel MA, Berger MS, Godfrey T, Nigro
J, Prados M, Chang S, Barker FG 2nd, Aldape K.
Analysis
of complex relationships
between age, p53, epidermal growth factor receptor, and survival
in
glioblastoma patients.
Cancer
Res. 2001 Feb 1;61(3):1122-8∟.
PMID: 11221842∟.
Observational study. ˍ
Yu JS, Wheeler CJ, Zeltzer PM, Ying
H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger
MS, Zhang W, Prins RM, Black KL.
Vaccination
of malignant glioma patients with peptide-pulsed dendritic cells
elicits systemic cytotoxicity and intracranial T-cell
infiltration.
Cancer
Res. 2001 Feb 1;61(3):842-7∟. PMID: 11221866∟.
Interventional study. ˍ
Fisher BJ, Scott C, Macdonald DR,
Coughlin C, Curran WJ.
Phase
I study of topotecan plus cranial radiation for glioblastoma
multiforme: results of Radiation Therapy Oncology Group Trial
9507.
J Clin
Oncol. 2001 Feb 15;19(4):1111-7∟.
doi: 10.1200/JCO.2001.19.4.1111∟.
PMID: 11181676∟.
Interventional study. ˍ
Geoerger B, Kerr K, Tang CB, Fung
KM, Powell B, Sutton LN, Phillips PC, Janss AJ.
Antitumor
activity of the rapamycin analog CCI-779 in human primitive
neuroectodermal tumor/medulloblastoma models as single agent and
in combination chemotherapy.
Cancer
Res. 2001 Feb 15;61(4):1527-32∟.
PMID: 11245461∟.
Laboratory investigation. ˍ